Health-related quality of life before and after liver transplantation in patients with primary sclerosing cholangitis

References

• Talwalkar JA, Lindor KD. Primary sclerosing cholangitis. Inflamm Bowel Dis. 2005;11(1):62–72.
   PubMed Web of Science ®Google Scholar
• Boyd S, Tenca A, Jokelainen K, et al. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia. Endoscopy. 2016;48:432–439.
   PubMed Web of Science ®Google Scholar
• Ponsioen CY. Recent insights in primary sclerosing cholangitis. J Dig Dis. 2012;13(7):337–341.
   PubMed Web of Science ®Google Scholar
• Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58(6):2045–2055.
   PubMed Web of Science ®Google Scholar
• Arndtz K, Hirschfield GM. Quality of life and primary sclerosing cholangitis: the business of defining what counts. Hepatology. 2018;68(1):16–18.
   PubMed Web of Science ®Google Scholar
• Zakharia K, Tabibian A, Lindor KD, et al. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int. 2018;38(3):399–411.
   PubMed Web of Science ®Google Scholar
• Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36(3):321–327.
   PubMed Web of Science ®Google Scholar
• Manninen P, Karvonen AL, Laukkarinen J, et al. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease. Scand J Gastroenterol. 2015;50(4):423–428.
   PubMed Web of Science ®Google Scholar
• Tabibian JH, Ali AH, Lindor KD. Primary sclerosing cholangitis, part 1: epidemiology, etiopathogenesis, clinical features, and treatment. Gastroenterol Hepatol (N Y). 2018;14(5):293–304.
   PubMedGoogle Scholar
• Boyd S, Vannas M, Jokelainen K, et al. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis. WJG. 2017;23(33):6147–6154.
   PubMed Web of Science ®Google Scholar
• Vannas MJ, Boyd S, Färkkilä MA, et al. Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis. Liver Int. 2017;37(5):735–742.
   PubMed Web of Science ®Google Scholar
• Bonato G, Cristoferi L, Strazzabosco M, et al. Malignancies in primary sclerosing cholangitis–a continuing threat. Dig Dis. 2015;33(2):140–148.
   PubMed Web of Science ®Google Scholar
• Neuberger J. Liver transplantation for cholestatic liver disease. Curr Treat Options Gastroenterol. 2003;6(2):113–121.
   PubMedGoogle Scholar
• Åberg F, Rissanen AM, Sintonen H, et al. Health-related quality of life and employment status of liver transplant patients. Liver Transpl. 2009;15(1):64–72.
   PubMed Web of Science ®Google Scholar
• Haapamäki J, Tenca A, Sintonen H, et al. Health-related quality of life among patients with primary sclerosing cholangitis. Liver Int. 2015;35(9):2194–2201.
   PubMed Web of Science ®Google Scholar
• Boyd S, Mustonen H, Tenca A, et al. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma. Scand J Gastroenterol. 2017;52(2):242–249.
   PubMed Web of Science ®Google Scholar
• Sintonen H. The 15D-measure of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system.pdf. Melbourne: National Centre for Health Program Evaluation, Working Paper 41; 1994.
   Google Scholar
• Sintonen H. The 15D-measure of health-related quality of life. II. Feasibility, reliability and validity of its valuation system.pdf. Melbourne: National Centre for Health Program Evaluation, Working Paper 42; 1995.
   Google Scholar
• Koskinen S, Lundqvist A, Ristiluoma N, et al. Terveys, toimintakyky ja hyvinvointi Suomessa 2011. 2012. Available from: http://urn.fi/URN:ISBN:978-952-245-769-1
   Google Scholar
• Aromaa A ,Koskinen S. Health and functional capacity in Finland: baseline results of the Health 2000 health examination survey. Helsinki: Publication B12, National Public Health Institute; 2004.
   Google Scholar
• QUALITY OF LIFE QUESTIONNAIRE (15D©). Available from: http://www.15d-instrument.net/site/assets/files/1002/15d_english.pdf.
   Google Scholar
• Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33(5):328–336.
   PubMed Web of Science ®Google Scholar
• Alanne S, Roine RP, Räsänen P, et al. Estimating the minimum important change in the 15D scores. Qual Life Res. 2015;24(3):599–606.
   PubMed Web of Science ®Google Scholar
• Andersen IM, Fosby B, Boberg KM, et al. Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway. Transplant Direct. 2015;1(9):e39.
   PubMed Web of Science ®Google Scholar
• Åberg F, Gissler M, Karlsen TH, et al. Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study. Hepatology. 2015;61(2):668–677.
   PubMed Web of Science ®Google Scholar
• Rodrigue JR, Hanto DW, Curry MP. Patients’ expectations and success criteria for liver transplantation. Liver Transpl. 2011;17(11):1309–1317.
   PubMed Web of Science ®Google Scholar
• Brandsaeter B, Isoniemi H, Broomé U, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol. 2004;40(5):815–822.
   PubMed Web of Science ®Google Scholar
• Cheung AC, Patel H, Meza-Cardona J, et al. Factors that influence health-related quality of life in patients with primary sclerosing cholangitis. Dig Dis Sci. 2016;61(6):1692–1699.
   PubMed Web of Science ®Google Scholar
• Estraviz B, Quintana JM, Valdivieso A, et al. Factors influencing change in health-related quality of life after liver transplantation. Clin Transplant. 2007;21(4):481–499.
   PubMed Web of Science ®Google Scholar